John F Crowley
CIK 1400973 · Executive Chairman · last filed 2024-03-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$347.8K
Companies
3
Total Filings
233
Lifetime Open-Market Net
-$53.88M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Executive Chairman | 991,908 | $14.49 | $14.37M | -$52.33M | 193 | 2024-03-15 |
| NTLA | Director | 11,716 | $10.75 | $125.9K | -$1.60M | 6 | 2023-06-16 |
| TRDA | Director | 37,864 | $5.86 | $221.9K | $48.6K | 4 | 2023-06-12 |
Recent Filings · Page 16 of 24
233 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-02 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | — | -$173.1K | EDGAR |
| 2019-06-18 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −205 | -$2.3K | EDGAR |
| 2019-06-04 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | — | -$146.7K | EDGAR |
| 2019-05-02 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | — | -$193.8K | EDGAR |
| 2019-04-15 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +82,318 | $0 | EDGAR |
| 2019-04-03 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | — | -$202.7K | EDGAR |
| 2019-03-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | — | -$201.1K | EDGAR |
| 2019-02-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | — | -$165.9K | EDGAR |
| 2019-01-17 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | — | -$140.0K | EDGAR |
| 2019-01-10 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +233,477 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.